CDNA vs. BABA
CDNA (CareDx, Inc) and BABA (Alibaba Group Holding Limited) are both stocks. CDNA operates in Diagnostics & Research (Healthcare), while BABA operates in Internet Retail (Consumer Cyclical). Over the past 10 years, CDNA returned 25.04%/yr vs 4.48%/yr for BABA. Their 0.19 correlation means their historical movements had little consistent relationship.
Performance
CDNA vs. BABA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CDNA achieves a 132.01% return, which is significantly higher than BABA's -15.83% return. Over the past 10 years, CDNA has outperformed BABA with an annualized return of 25.04%, while BABA has yielded a comparatively lower 4.48% annualized return.
CDNA
- 1D
- 14.72%
- 1M
- 49.74%
- 6M
- 112.70%
- YTD
- 132.01%
- 1Y
- 257.69%
- 3Y*
- 60.92%
- 5Y*
- -12.26%
- 10Y*
- 25.04%
- ALL TIME*
- 13.52%
BABA
- 1D
- 5.10%
- 1M
- 27.16%
- 6M
- -27.24%
- YTD
- -15.83%
- 1Y
- 5.38%
- 3Y*
- 9.08%
- 5Y*
- -7.82%
- 10Y*
- 4.48%
- ALL TIME*
- 2.89%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $1.13B | $1.37B | $1.51B | |
CDNA CareDx, Inc | $44.41M | $43.11M | $27.26M |
CDNA vs. BABA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CDNA CareDx, Inc | 132.01% | -12.00% | 78.42% | 5.17% | -74.91% | -37.23% | 235.88% | -14.20% | 242.51% | 171.85% |
BABA Alibaba Group Holding Limited | -15.83% | 75.80% | 11.77% | -10.83% | -25.84% | -48.96% | 9.73% | 54.74% | -20.51% | 96.37% |
Correlation
The correlation between CDNA and BABA is 0.16, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.16 |
Correlation (3Y) Balances recent behavior with more history. | 0.15 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.25 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.22 |
Correlation (All Time) Calculated using the full available price history since Sep 19, 2014 | 0.19 |
Fundamentals
CDNA:
$2.26B
BABA:
$293.02B
CDNA:
$2.10
BABA:
CN¥33.85
CDNA:
20.81
BABA:
24.38
CDNA:
0.03
BABA:
1.09
CDNA:
5.04
BABA:
2.45
CDNA:
5.49
BABA:
1.89
CDNA:
$458.09M
BABA:
CN¥811.51B
CDNA:
$225.02M
BABA:
CN¥332.88B
CDNA:
$129.64M
BABA:
CN¥112.44B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CDNA vs. BABA — Risk / Return Rank
CDNA
BABA
CDNA vs. BABA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for CareDx, Inc (CDNA) and Alibaba Group Holding Limited (BABA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CDNA | BABA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +3.53 | ||
| Sortino ratioReturn per unit of downside risk | +4.14 | ||
| Omega ratioGain probability vs. loss probability | 1.54 | 1.05 | +0.49 |
| Calmar ratioReturn relative to maximum drawdown | 10.90 | 0.05 | +10.85 |
| Martin ratioReturn relative to average drawdown | 32.58 | 0.09 | +32.49 |
Loading charts...
Drawdowns
CDNA vs. BABA - Drawdown Comparison
The maximum CDNA drawdown since its inception was -94.87%, which is greater than BABA's maximum drawdown of -80.09%. Use the drawdown chart below to compare losses from any high point for CDNA and BABA.
Loading charts...
Drawdown Indicators
| CDNA | BABA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.87% | -80.09% | -14.78% |
Max Drawdown (1Y)Largest decline over 1 year | -23.64% | -49.47% | +25.83% |
Max Drawdown (3Y)Largest decline over 3 years | -65.96% | -49.47% | -16.49% |
Max Drawdown (5Y)Largest decline over 5 years | -94.19% | -68.54% | -25.65% |
Max Drawdown (10Y)Largest decline over 10 years | -94.87% | -80.09% | -14.78% |
Current DrawdownCurrent decline from peak | -54.28% | -59.04% | +4.76% |
Average DrawdownAverage peak-to-trough decline | -53.87% | -37.84% | -16.03% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.89% | 24.79% | -16.90% |
Volatility
CDNA vs. BABA - Volatility Comparison
CareDx, Inc (CDNA) has a higher volatility of 35.19% compared to Alibaba Group Holding Limited (BABA) at 14.17%. This indicates that CDNA's price experiences larger fluctuations and is considered to be riskier than BABA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CDNA | BABA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 35.19% | 14.17% | +21.02% |
Volatility (6M)Calculated over the trailing 6-month period | 53.85% | 29.11% | +24.74% |
Volatility (1Y)Calculated over the trailing 1-year period | 72.08% | 45.09% | +26.99% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 79.44% | 51.60% | +27.84% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 79.08% | 43.64% | +35.44% |
Dividends
CDNA vs. BABA - Dividend Comparison
CDNA has not paid dividends to shareholders, while BABA's dividend yield for the trailing twelve months is around 0.86%.
| Position | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
BABA Alibaba Group Holding Limited | 0.86% | 1.36% | 1.96% | 1.29% |
CDNA CareDx, Inc | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
CDNA vs. BABA - Financials Comparison
This section allows you to compare key financial metrics between CareDx, Inc and Alibaba Group Holding Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CDNA vs. BABA - Profitability Comparison
CDNA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, CareDx, Inc reported a gross profit of 0.00 and revenue of 131.95M. Therefore, the gross margin over that period was 0.0%.
BABA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Alibaba Group Holding Limited reported a gross profit of 11.75B and revenue of 35.15B. Therefore, the gross margin over that period was 33.4%.
CDNA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, CareDx, Inc reported an operating income of 113.22M and revenue of 131.95M, resulting in an operating margin of 85.8%.
BABA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Alibaba Group Holding Limited reported an operating income of -135.47M and revenue of 35.15B, resulting in an operating margin of -0.4%.
CDNA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, CareDx, Inc reported a net income of 110.64M and revenue of 131.95M, resulting in a net margin of 83.9%.
BABA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Alibaba Group Holding Limited reported a net income of 3.69B and revenue of 35.15B, resulting in a net margin of 10.5%.
Frequently Asked Questions
CDNA and BABA have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CDNA has higher volatility (35.19%) compared to BABA (14.17%). In terms of maximum drawdown, CDNA dropped -94.87% vs BABA's -80.09%.
CDNA currently has the higher Sharpe Ratio (3.58 vs 0.05), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CDNA and BABA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer